Orphenadrine Citrate-CAPLIN-30 mg/ml-100 amp w/2mlSAIMED

Code

Orphenadrine Citrate-CAPLIN-INJ

$0.00

Description

Orphenadrine Citrate-CAPLIN-30 mg/mL is a sterile, fast-acting injectable formulation indicated for the relief of acute, painful musculoskeletal conditions. Operating as a centrally acting skeletal muscle relaxant, orphenadrine targets the central nervous system to effectively disrupt muscle spasms and diminish associated pain without directly relaxing tense muscles.

This preparation is packaged in 2 mL ampoules (containing a total of 60 mg of Orphenadrine Citrate per ampoule) and is designed for convenient clinical administration via Intramuscular (IM) or Intravenous (IV) routes.

Technical & Product Specifications

Attribute Product Details
Brand / Manufacturer Caplin
Active Ingredient Orphenadrine Citrate
Concentration 30 mg / mL
Volume per Ampoule 2 mL (Total 60 mg per ampoule)
Dosage Form Injection Solution
Route of Administration Intramuscular (IM) / Intravenous (IV)
Packaging Configuration Box of 100 Ampoules
Sales Unit Sold by Individual Units (Amps)

Primary Therapeutic Indications

  • Acute Muscle Spasms: Rapid relief of severe, painful spasms associated with acute localized musculoskeletal trauma.

  • Adjunctive Therapy: Utilized alongside rest, physical therapy, and other symptomatic relief measures to accelerate recovery from skeletal muscle injuries.

  • Strains and Sprains: Indicated for severe back pain, neck strains, or related joint/muscle injuries where oral muscle relaxants are impractical or insufficient.

Key Benefits & Features

  • Rapid Onset of Action: Direct IV or IM injection bypasses the digestive tract, offering swift therapeutic intervention for patients experiencing debilitating muscle pain.

  • Dual Route Flexibility: Can be administered via deep intramuscular injection or slow intravenous injection depending on clinical urgency and patient needs.

  • Flexible Purchasing: Available for procurement by the individual ampoule, offering excellent inventory flexibility for hospitals, emergency clinics, and private medical practices.

Usage, Storage & Safety Information

  • Administration: Must be administered solely by a licensed healthcare professional. When given intravenously, the solution should be injected slowly over a period of approximately 5 minutes to minimize transient side effects.

  • Storage: Store at room temperature (below 30°C). Protect from direct light and moisture. Do not freeze. Keep out of reach of children.

  • Contraindications & Precautions: Contraindicated in patients with glaucoma, pyloric or duodenal obstruction, prostatic hypertrophy, bladder neck obstructions, or myasthenia gravis. May cause transient dizziness or drowsiness; patients should be monitored accordingly post-injection.

Regulatory Note: This product is a prescription-only pharmaceutical solution intended for clinical, institutional, and pharmacy supply use. Valid medical authorization is required for purchase.